SOPH logo

SOPH
SOPHiA Genetics SA

261
Mkt Cap
$359.06M
Volume
158.00
52W High
$5.70
52W Low
$2.59
PE Ratio
-4.24
SOPH Fundamentals
Price
$5.01
Prev Close
$5.01
Open
$5.02
50D MA
$4.95
Beta
0.91
Avg. Volume
95,955.82
EPS (Annual)
-$1.17
P/B
7.87
Rev/Employee
$186,195.18
$308.14
Loading...
Loading...
News
all
press releases
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the...
News Placeholder
More News
News Placeholder
SOPHiA GENETICS (NASDAQ:SOPH) Earns Buy Rating from BTIG Research
BTIG Research restated a "buy" rating and set a $8.00 target price on shares of SOPHiA GENETICS in a report on Wednesday...
News Placeholder
SOPHiA GENETICS Q1 Earnings Call Highlights
SOPHiA GENETICS (NASDAQ:SOPH) reported first-quarter 2026 revenue of $21.7 million, up 22% from $17.8 million in the prior-year period, as demand increased for its SOPHiA DDM analytics platform and the company expanded its installed base of clinical customers and applications. Revenue growth and re...
News Placeholder
SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
News Placeholder
SOPHiA GENETICS (NASDAQ:SOPH) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS
SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of...
News Placeholder
SOPHiA GENETICS Reports First Quarter 2026 Results
SOPHiA GENETICS Reports First Quarter 2026 Results SOPHiA GENETICS Reports First Quarter 2026 Results PR Newswire BOSTON and ROLLE, Switzerland, May 5, 2026 BOSTON and ROLLE, Switzerland, May 5, 2026...
News Placeholder
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,100.00 in Stock
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) insider Philippe Menu sold 5,000 shares of the business's stock in a transaction dated Monday, April 27th. The stock was sold at an average price of...
News Placeholder
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Drops By 31.0%
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totaling 175,963 shares, a...
News Placeholder
SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday
SOPHiA GENETICS (NASDAQ:SOPH) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
News Placeholder
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?
TEM faces pressure ahead of Q1 earnings as macro headwinds, high valuation and estimate trends cloud its near-term investment appeal.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available